Skip to main content

Published locations for Adalimumab is good first-line anti-TNF therapy for pediatric Crohn’s disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adalimumab is good first-line anti-TNF therapy for pediatric Crohn’s disease

User login

  • Reset your password
  • /content/adalimumab-good-first-line-anti-tnf-therapy-pediatric-crohns-disease
  • /familypracticenews/article/137811/gastroenterology/adalimumab-good-first-line-anti-tnf-therapy
  • /gihepnews/article/137811/gastroenterology/adalimumab-good-first-line-anti-tnf-therapy-pediatric
  • /pediatricnews/article/137811/gastroenterology/adalimumab-good-first-line-anti-tnf-therapy-pediatric
  • /pediatrics/article/137811/gastroenterology/adalimumab-good-first-line-anti-tnf-therapy-pediatric
  • /familymedicine/article/137811/gastroenterology/adalimumab-good-first-line-anti-tnf-therapy-pediatric